By co-expression of human SERPINA3 with human APP in a transgenic murine model of Alzheimer’s disease, author found increased rate of disease progression indicating human ACT as amyloidogenic cofactor in AD pathogenesis [45]. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.